Phase II study of G3139, a Bcl-2 antisense oligonucleotide, in combination with dexamethasone and thalidomide in relapsed multiple myeloma patients (Q33366083)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase II study of G3139, a Bcl-2 antisense oligonucleotide, in combination with dexamethasone and thalidomide in relapsed multiple myeloma patients |
scientific article |
Statements
1 reference
Phase II study of G3139, a Bcl-2 antisense oligonucleotide, in combination with dexamethasone and thalidomide in relapsed multiple myeloma patients (English)
1 reference
Jodi A Flaws
1 reference
Ashraf Z Badros
1 reference
Olga Goloubeva
1 reference
Aaron P Rapoport
1 reference
Bashi Ratterree
1 reference
Natalie Gahres
1 reference
Barry Meisenberg
1 reference
Naoko Takebe
1 reference
Meyer Heyman
1 reference
James Zwiebel
1 reference
Howard Streicher
1 reference
Christopher D Gocke
1 reference
Dragana Tomic
1 reference
Bin Zhang
1 reference
Robert G Fenton
1 reference
1 reference
Identifiers
1 reference